Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Amgen4,968 enrolled

Overview

The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.

Study Type

OBSERVATIONAL

Enrollment

4,968

Conditions

Rheumatoid Arthritis

Interventions

DMARDDRUG

All subjects were required to initiate, add or change DMARD therapy at study entry.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Fulfillment of the 1987 American Rheumatism Association criteria for RA * Currently requiring a new DMARD (change or addition) Exclusion Criteria: * Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol * Nursing or pregnant women * Patients with active infection

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.